Dr. Rangwala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Duke Medical Ctr
# 10
Durham, NC 27710Phone+1 919-681-2954
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2008 - 2011
- Duke University HospitalResidency, Internal Medicine, 2005 - 2008
- University of Cincinnati College of MedicineClass of 2005
Certifications & Licensure
- NC State Medical License 2011 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 8 citationsLIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade.Kyung Jin Yoo, Kellsey Johannes, Louis E González, Arpita Patel, Casey W Shuptrine
Journal of Immunology. 2022-08-01 - 32 citationsBRAF-Mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal ...Gary Middleton, Yiqun Yang, Catarina D. Campbell, Thierry André, Chloe E. Atreya
Clinical Cancer Research. 2020-02-11 - 8 citationsA phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerJohn H. Strickler, Christel Rushing, Donna Niedzwiecki, Abigail B. McLeod, Ivy Altomare
BMC Cancer. 2019-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: